"They have to be used in a therapeutic manner with attention to the indications, effects, and side effects." Hone Health surveyed 2,491 U.S
The weekly formulations were launched around 10 years ago, but it was the launches of liquid-stable weekly formulations, such as Eli Lillys Trulicity (dulaglutide) in 2014, Novo Nordisks Ozempic (semaglutide) in 2017, and Mounjaro (tirzepatide), again from Lilly, in 2022, that is transforming the treatment of Type 2 diabetes today
Understanding the Three Receptor Targets One of the defining characteristics of Retatrutide is its ability to interact with multiple biological pathways
Ultimately, there are both negative side effects and risks to be aware of, which is what well discuss next